A major advance in cancer research is emerging with the use of VHH fragments to re-engage damaged p53. This vital malignant inhibitor protein is frequently inactivated in many kinds of tumors, causing uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research